The mutations in the KRas and CDKN2A oncogenes, as well as the p53 tumor suppressor gene, result in the continuous proliferation of cancer cells and contribute to the formation of cancer stem cells [51,52,53,54,55,56]. The gene discussed is KRAS; the disease is cancer.